GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. (Q2905968): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: budget (P474): 166,566.0 euro) |
(Changed an Item: modifying budgets in portugal one item from slovenia) |
||||||
| Property / budget | |||||||
195,960.0 Euro
| |||||||
| Property / budget: 195,960.0 Euro / rank | |||||||
Normal rank | |||||||
| Property / EU contribution | |||||||
166,566.0 Euro
| |||||||
| Property / EU contribution: 166,566.0 Euro / rank | |||||||
Normal rank | |||||||
| Property / co-financing rate | |||||||
85.0 percent
| |||||||
| Property / co-financing rate: 85.0 percent / rank | |||||||
Normal rank | |||||||
Revision as of 22:26, 21 October 2021
Project Q2905968 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. |
Project Q2905968 in Portugal |
Statements
166,566.0 Euro
0 references
195,960.0 Euro
0 references
85.0 percent
0 references
1 July 2016
0 references
31 December 2019
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016601
0 references